Characterisation and comparison of recombinant human follicle-stimulating hormones

Journal of Clinical Research

Volumn 4, Issue 91-104, 2001, Pages 91-104

  Bagatti, G ^a   Crisci, C ^a   Datola, A ^a   Gostoli, G ^a   Mascia, M ^a   Polletta, P ^a   Roncalli, G ^a   Simoni, P ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Follicle stimulating hormone; Gonal F ; Infertility; Puregon ; Recombinant

Indexed keywords

ISOPROTEIN; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ACIDITY; ALPHA CHAIN; ARTICLE; BETA CHAIN; BIOCHEMISTRY; COMPARATIVE STUDY; DRUG ACTIVITY; DRUG MANUFACTURE; DRUG OXIDATION; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; PHYSICAL CHEMISTRY;

EID: 0035664028     PISSN: 13695207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Pituitary glycoprotein hormone oligosaccharides: Structure, synthesis and function of asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin
2. Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon)
3. Genetic engineering of human FSH (Gonal-F)
4. Recombinant follicle stimulating hormone: Development of the first biotechnology product for the treatment of infertility
5. Gonadotrophin heterogeneity and biopotency: Implications for assisted reproduction
6. Adverse local reaction to intramuscular injections of urinary-derived gonadotrophins
7. Composition of commercial gonadotrophin preparations extracted from human post-menopausal urine: Characterization of non-gonadotrophin proteins
8. Invitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin HP
9. Local side effects of subcutaneous and intramuscular urinary gonadotropins for ovarian stimulation in in vitro fertilization: A prospective, randomized study
10. Effects of urinary gonadotrophin preparations on human in-vitro immune function
11. Recombinant follicle-stimulating hormone in a patient hypersensitive to urinary-derived gonadotropins
12. A biological, immunological and physico-chemical comparison of the current clinical batches of the recombinant follicle stimulating hormone preparations Gonal-F and Puregon
13. Follicle-stimulating isohormones: Characterization and physiological relevance
14. Internal carbohydrate complexity of the oligosaccharide chains of recombinant human follicle stimulating hormone (Puregon, Org 32489): A comparison with Metrodin and Metrodin HP
15. Immunological and biological potencies of the different molecular species of gonadotrophins
16. Molecular structures of glycoprotein hormones and functions of their carbohydrate components
17. In-vitro biopotency of two glycoform mixtures of differing acidity derived from recombinant FSH measured using a human granulosalutein cell bioassay
18. Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis
19. More basic forms of both human follicle-stimulating hormone and luteinizing hormone at mid-cycle compared with the follicular and luteal phase
20. Dynamics of basal and gonadotrophin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution throughout the human menstrual cycle
21. Glycoform composition of serum gonadotrophins through the normal menstrual cycle and in the post-menopausal state
22. Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotrophin
23. Biological characterization of recombinant human follicle stimulating hormone isoforms
24. Predictions of the in vivo biological activity of human recombinant follicle stimulating hormone using quantitative isoelectric focusing
25. Responses of patients to different lots of human menopausal gonadotropins during controlled ovarian hyperstimulation
26. Heterogeneity of follicle stimulating hormone: Control and physiological function